The Candida glabrata Upc2A transcription factor is a global regulator of antifungal drug resistance pathways
Open accessAbstract
The most commonly used antifungal drugs are the azole compounds, which interfere with biosynthesis of the fungal-specific sterol: ergosterol. The pathogenic yeast Candida glabrata commonly acquires resistance to azole drugs like fluconazole via mutations in a gene encoding a transcription factor called PDR1 . These PDR1 mutations lead to overproduction of drug transporter proteins like the ATP-binding cassette transporter Cdr1. In other Candida species, mutant forms of a transcription factor called Upc2 are associated with azole resistance, owing to the important role of this protein in control of expression of genes encoding enzymes involved in the ergosterol biosynthetic pathway. Recently, the C . glabrata Upc2A factor was demonstrated to be required for normal azole resistance, even in the presence of a hyperactive mutant form of PDR1 . Using genome-scale approaches, we define the network of genes bound and regulated by Upc2A. By analogy to a previously described hyperactive UPC2 mutation found in Saccharomyces cerevisiae , we generated a similar form of Upc2A in C . glabrata called G898D Upc2A. Analysis of Upc2A genomic binding sites demonstrated that wild-type Upc2A binding to target genes was strongly induced by fluconazole while G898D Upc2A bound similarly, irrespective of drug treatment. Transcriptomic analyses revealed that, in addition to the well-described ERG genes, a large group of genes encoding components of the translational apparatus along with membrane proteins were responsive to Upc2A. These Upc2A-regulated membrane protein-encoding genes are often targets of the Pdr1 transcription factor, demonstrating the high degree of overlap between these two regulatory networks. Finally, we provide evidence that Upc2A impacts the Pdr1-Cdr1 system and also modulates resistance to caspofungin. These studies provide a new perspective of Upc2A as a master regulator of lipid and membrane protein biosynthesis.
AI snapshot
Written from the paper’s full text.
TL;DR
Upc2A in *Candida glabrata* is a global transcriptional regulator that binds over 1,000 promoters under fluconazole stress and overlaps extensively with the Pdr1 regulon. A constructed G898D gain-of-function Upc2A confers elevated fluconazole resistance and constitutively binds targets, while loss of Upc2A reduces FKS1 expression and increases caspofungin sensitivity.
Key findings
- ChIP-seq identified >1,000 Upc2A-bound promoters in wild-type cells treated with fluconazole; 565 promoters were bound only under fluconazole, 309 were bound under all four conditions, and 85 were bound only under induced conditions.
- More than 50% of Pdr1 target promoters were also bound by Upc2A, and Upc2A binding sites were required for normal fluconazole induction of *CDR1* and *PDR1*; loss of the *CDR1* SRE caused the largest reduction in fluconazole resistance.
- RNA-seq showed that only 53 fluconazole-induced genes required Upc2A binding for induction, while 542 fluconazole-induced genes were not dependent on Upc2A; 64 genes required Upc2A but were not bound by it, including *ERG4*, *ERG8*, *ERG9*, *ERG24*, *ERG26*, and *ERG27*.
- The G898D Upc2A allele elevated fluconazole resistance and increased only 11 genes at least 1.4-fold, 9 of which were ergosterol biosynthesis genes; loss of *UPC2A* reduced basal *FKS1* expression by 50% and *FKS2* by 30%, and caused hypersensitivity to caspofungin, caffeine, and high pH.
Methods
- Isogenic *C. glabrata* strains varying in *UPC2A* allele, including wild-type, *upc2AΔ*, 3X HA-tagged wild-type, and 3X HA-G898D *UPC2A*, were grown with or without fluconazole and assayed by serial dilution, RT-qPCR, western blotting, and β-galactosidase reporter assays.
- ChIP-seq with anti-HA was performed on wild-type and G898D Upc2A with or without fluconazole; peaks were called with MACS2, differential binding with BDGdiff, and motifs with MEME-ChIP. RNA-seq compared wild-type and *upc2AΔ* cells with or without fluconazole, and wild-type versus G898D *UPC2A* without fluconazole.
- DNA binding was validated by DNase I protection and EMSA using recombinant Upc2A DNA-binding domain and wild-type or mutant SRE probes from *ERG1*, *CDR1*, *PDR1*, and *FKS1* promoters.
Limitations
- The paper states that a large group of Upc2A-bound genes, including translational machinery components, “await experimental analysis to test their functionality,” and that the molecular basis of G898D Upc2A transcriptional effects is “still only partially understood.”
- The paper notes that further dissection of the Upc2A regulon is required to illuminate modes of control for genes regulated in the presence or absence of Upc2A, and that experiments testing G898D Upc2A under fluconazole are underway.
- Evident from the text: the G898D allele was engineered by analogy to *S. cerevisiae* and is not a naturally occurring *C. glabrata* allele; many conclusions rely on laboratory strain backgrounds and in vitro binding assays rather than clinical isolates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 39 cited sources checked · 0 supported · 0 flagged
- Findingown data
The G898D mutant form of Upc2A confers elevated fluconazole resistance in C. glabrata.
“This mutant Upc2A drove elevated fluconazole resistance and behaved like the hyperactive S. cerevisiae factor.”
- Also stated in: § A gain-of-function form of Upc2A confers elevated fluconazole resistance · plain
“Introduction of the G898D mutation into UPC2A led to the resulting factor exhibiting elevated fluconazole resistance when compared to either the tagged or untagged version of the wild-type gene.”
Quote in the paperSubstantial claim - Also stated in: § A gain-of-function form of Upc2A confers elevated fluconazole resistance · plain
- Findingown data
Loss of UPC2A causes a dramatic increase in fluconazole susceptibility.
“Loss of UPC2A caused a dramatic increase in fluconazole susceptibility.”
Quote in the paperSubstantial claim - Findingown data
ERG11 is an example of a locus controlled by Upc2A but not Pdr1.
“The ERG11 gene is an example of a locus controlled by Upc2A but not Pdr1.”
Quote in the paperNot a substantial claim - Findingown data
The large group of Upc2A-bound genes includes loci not typically considered as target genes, such as components of the translational machinery.
“This large group of Upc2A-bound genes include loci not typically considered as target genes, such as components of the translational machinery”
Quote in the paperNot a substantial claim - Findingown data
The third largest class of promoters (85) were only bound by Upc2A under induced conditions (wild-type + fluconazole and G898D Upc2A +/- fluconazole).
“The third largest class of promoters (85) were only bound by Upc2A under conditions we consider induced (wild-type + fluconazole and G898D Upc2A +/- fluconazole).”
Quote in the paperNot a substantial claim
- Findingown data
There were 565 promoters that could only be bound by Upc2A in the presence of fluconazole.
“Interestingly, there were 565 of these promoters that could only be bound by Upc2A in the presence of fluconazole while others were bound in multiple different conditions.”
Quote in the paperSubstantial claim - Findingown data
The top 4 GO terms enriched in genes bound by both Upc2A and Pdr1 were associated with transmembrane transport or integral membrane components.
“The top 4 GO terms enriched in genes bound by both these Zn2Cys6-containing transcription factors were associated with transmembrane transport or integral membrane components (S2 Table).”
Quote in the paperNot a substantial claim - Findingown data
The largest number of Upc2A-bound genes was seen for the wild-type factor in the presence of fluconazole (>1000 promoters bound).
“The largest number of bound genes was seen for the wild-type factor in the presence of fluconazole (>1000 promoters bound).”
Quote in the paperSubstantial claim - Findingown data
Over a two-hour fluconazole challenge, no differences in the levels of wild-type and G898D Upc2A are seen.
“Over the time course of fluconazole challenge (two hours), no differences in the levels of these two forms of Upc2A were seen.”
Quote in the paperSubstantial claim - Findingown data
GO term enrichment analysis indicated that very different genes were associated with the three patterns of Upc2A DNA-binding.
“GO term enrichment analysis of these three different classes of promoters indicated that very different genes were associated with these patterns of Upc2A DNA-binding.”
Quote in the paperNot a substantial claim - Findingown data
Alignment of C. glabrata Upc2A and ScUpc2 indicated that G898 is the analogous position in Upc2A.
“Alignment of C. glabrata Upc2A and ScUpc2 indicated that G898 was the analogous position in Upc2A.”
Quote in the paperSubstantial claim - Findingown data
Binding of wild-type Upc2A increases in the presence of fluconazole compared to absence of drug.
“Binding of wild-type Upc2A is represented by the read depth and can be seen to increase in the presence of fluconazole compared to in the absence of the drug.”
Quote in the paperSubstantial claim - Findingown data
The class of genes bound under all 4 conditions was most predominantly enriched for proteins associated with the plasma membrane.
“The class of genes bound under all 4 different conditions was most predominantly enriched for proteins associated with the plasma membrane (S1B Table)”
Quote in the paperNot a substantial claim - Findingown data
Fluconazole elevates PDR1 and CDR1 by 4- or 7-fold, respectively, when wild-type UPC2A is present.
“The presence of fluconazole elevated PDR1 and CDR1 by 4- or 7-fold, respectively when the wild-type UPC2A gene was present.”
Quote in the paperSubstantial claim - Findingown data
The ScUpc2 SREs are most closely fit to the right-hand element of the Upc2A SRE predicted by MEME-ChIP.
“These ScUpc2 SREs are most closely fit to the right-hand element of the Upc2A SRE predicted by MEME-ChIP.”
Quote in the paperNot a substantial claim - Findingown data
Transcription of the FKS1 gene, encoding a β-glucan synthase protein, is responsive to Upc2A.
“Transcription of the FKS1 gene, encoding a β-glucan synthase protein was also found to be responsive to Upc2A”
Quote in the paperSubstantial claim - Findingown data
The inducible class of Upc2A-bound promoters showed the strongest enrichment for genes involved in fatty acid biosynthesis.
“the inducible class of Upc2A-bound promoters showed the strongest enrichment for genes involved in fatty acid biosynthesis (S1C Table).”
Quote in the paperNot a substantial claim - Findingown data
Comparison of genes bound by Upc2A with those previously found associated with Pdr1 indicated a high degree of overlap between these two target gene suites.
“Comparison of the genes bound by Upc2A with those we previously found to be associated with Pdr1 indicated a high degree of overlap between these two target gene suites.”
- Also stated in: § Overlap between Upc2A- and Pdr1-controlled genes by ChIP-seq · plain
“Strikingly, more than 50% of Pdr1 target promoters were also associated with Upc2A binding (Fig 2C).”
Quote in the paperSubstantial claim - Also stated in: § Overlap between Upc2A- and Pdr1-controlled genes by ChIP-seq · plain
- Findingreasoning
upc2AΔ strains are hypersensitive to caspofungin.
“consistent with upc2AΔ strains being hypersensitive to caspofungin”
Quote in the paperSubstantial claim - Findingown data
The next largest group of bound promoters (309) were bound under all 4 different conditions.
“The next largest group of bound promoters (309) were found to be bound under all 4 different conditions.”
Quote in the paperNot a substantial claim - Findingown data
UPC2A transcription is elevated approximately two-fold by fluconazole, irrespective of the UPC2A allele tested.
“UPC2A transcription was elevated approximately two-fold by fluconazole, irrespective of the UPC2A allele tested.”
Quote in the paperNot a substantial claim - Findingown data
More than 50% of Pdr1 target promoters were also associated with Upc2A binding.
“Strikingly, more than 50% of Pdr1 target promoters were also associated with Upc2A binding (Fig 2C).”
Quote in the paperSubstantial claim - Findingown data
The levels of wild-type and G898D forms of Upc2A are not detectably different by western blotting with anti-Upc2A antiserum.
“The levels of the wild-type and G898D forms of Upc2A were not detectably different as shown by blotting with the anti-Upc2A polyclonal antiserum.”
Quote in the paperSubstantial claim - Findingown data
Introduction of the G898D UPC2A allele modestly reduces fluconazole induction of PDR1 and CDR1 to 2-fold and 4-fold, respectively.
“Introduction of the G898D UPC2A allele modestly reduced fluconazole induction for these two genes to 2-fold for PDR1 and 4-fold for CDR1.”
Quote in the paperNot a substantial claim - Findingown data
Binding of G898D Upc2A is constant irrespective of the presence of drug.
“Binding of G898D Upc2A was constant, irrespective of the presence of the drug.”
Quote in the paperNot a substantial claim - Findingown data
The largest class of Upc2A-bound genes was enriched for components of the translation apparatus.
“The largest class of genes was enriched for components of the translation apparatus (S1A Table).”
Quote in the paperNot a substantial claim - Findingown data
None of the three FKS genes were altered in the presence of the gain-of-function form of UPC2A.
“None of these genes were altered in the presence of this gain-of-function form of UPC2A while both ERG1 and AUS1 were elevated (Fig 6B), confirming the functionality of this hypermorphic form of Upc2A.”
Quote in the paperSubstantial claim - Findingown data
GO terms enriched in the 53 direct target genes included ergosterol biosynthesis, plasma membrane and cell wall biogenesis, membrane transport, sterol uptake and RNA polymerase II core promoter-binding factors.
“GO terms enriched in this set of genes included ergosterol biosynthesis, plasma membrane and cell wall biogenesis, membrane transport, sterol uptake and RNA polymerase II core promoter-binding factors.”
Quote in the paperSubstantial claim - Findingown data
ERG1 contains an everted SRE repeat.
“Note that ERG1 contains an everted SRE repeat indicated by the arrows.”
Quote in the paperNot a substantial claim - Findingown data
Expression of Pdr1 was not affected when the CDR1 SRE was removed.
“Expression of Pdr1 was not affected when the CDR1 SRE was removed but fluconazole induction of Pdr1 was reduced when the SRE was removed from the PDR1 promoter.”
Quote in the paperNot a substantial claim - Findingown data
The only GO term enriched in the 64 genes that require Upc2A for FLC induction yet are not bound by Upc2A represents loci involved in ergosterol biosynthesis.
“The only GO term enriched in the 64 genes that require the presence of Upc2A for FLC induction (yet are not bound by Upc2A) represent loci involved in ergosterol biosynthesis.”
Quote in the paperSubstantial claim - Findingown data
The genes in this class of enriched genes include UPC2B and homologues of S. cerevisiae NRG2 and ADR1.
“The genes in this class of enriched genes include UPC2B and homologues of S. cerevisiae NRG2 and ADR1.”
Quote in the paperNot a substantial claim - Findingown data
Two ERG genes were exceptions to the general trends of ERG gene regulation by fluconazole and Upc2A.
“There were two ERG genes that were exceptions to these general trends of regulation.”
Quote in the paperNot a substantial claim - Findingown data
ERG10, ERG13, HMG1 and ERG20 were not influenced by fluconazole challenge in wild-type cells.
“ERG10, ERG13, HMG1 and ERG20, which all encode early steps in ergosterol biosynthesis, were not influenced by fluconazole challenge in wild-type cells although expression of these genes was strongly depressed under these same conditions in the absence of UPC2A.”
Quote in the paperSubstantial claim - Findingown data
The mutant form of the ERG1 SRE blocked formation of both complexes.
“The mutant form of this SRE blocked formation of both complexes.”
Quote in the paperSubstantial claim - Findingown data
QDR2 and RTA1 showed higher levels of fluconazole induction in the upc2AΔ strain.
“SNQ2 and PDH1 were reduced to approximately 50% of their normal drug-induced levels in the upc2AΔ strain while QDR2 and RTA1 showed higher levels of fluconazole induction in the same strain.”
Quote in the paperNot a substantial claim - Findingown data
The ChIP-seq data predicted a potential SRE upstream of the FKS1 and FKS2 genes.
“The ChIP-seq data predicted a potential SRE upstream of the FKS1 and FKS2 genes (S1 and S2 Tables).”
Quote in the paperNot a substantial claim - Findingown data
Five of these nine ergosterol biosynthesis genes also contained SREs.
“Five of these 9 genes also contained SREs.”
Quote in the paperNot a substantial claim - Findingown data
The majority of ERG genes showed at least two-fold induction by fluconazole in wild-type cells when they corresponded to steps later in the ergosterol biosynthetic pathway.
“The majority of ERG genes showed at least two-fold induction by fluconazole in wild-type cells as long as these genes corresponded to steps later in the ergosterol biosynthetic pathway.”
Quote in the paperSubstantial claim - Findingown data
ERG1 and AUS1 were elevated in the presence of the gain-of-function form of UPC2A.
“None of these genes were altered in the presence of this gain-of-function form of UPC2A while both ERG1 and AUS1 were elevated (Fig 6B), confirming the functionality of this hypermorphic form of Upc2A.”
Quote in the paperSubstantial claim - Findingreasoning
Expression of Erg11 was unaffected in these backgrounds.
“Expression of Erg11 was unaffected in these backgrounds as these alterations were restricted to the CDR1 and PDR1 promoters.”
Quote in the paperNot a substantial claim - Findingown data
PDR1 was similarly induced irrespective of the UPC2A background.
“CDR1 fluconazole induction was reduced upon loss of Upc2A but PDR1 was similarly induced irrespective of the UPC2A background (Fig 3B).”
Quote in the paperNot a substantial claim - Findingown data
The final and largest class of genes found to be bound by Upc2A were less than two-fold induced by fluconazole.
“The final and largest class of genes found to be bound by Upc2A were less than two-fold induced by fluconazole.”
Quote in the paperNot a substantial claim - Findingown data
Upc2A DNA-binding to CDR1 is regulated in a manner similar to that seen for ERG11.
“Upc2A DNA-binding to CDR1 was regulated in a manner similar to that seen for ERG11.”
Quote in the paperNot a substantial claim - Findingown data
These Upc2A-dependent but indirect targets include ERG4, ERG8, ERG9, ERG24, ERG26 and ERG27.
“These Upc2A-dependent but indirect targets include ERG4, ERG8, ERG9, ERG24, ERG26 and ERG27.”
Quote in the paperSubstantial claim - Findingown data
SNQ2 and PDH1 were reduced to approximately 50% of their normal drug-induced levels in the upc2AΔ strain.
“SNQ2 and PDH1 were reduced to approximately 50% of their normal drug-induced levels in the upc2AΔ strain while QDR2 and RTA1 showed higher levels of fluconazole induction in the same strain.”
Quote in the paperSubstantial claim - Findingown data
The presence of the GOF form of UPC2A caused relatively small changes in gene transcription.
“The presence of the GOF form of UPC2A caused relatively small changes in gene transcription.”
Quote in the paperNot a substantial claim - Findingown data
Introduction of the mSRE into ERG1, CDR1 or PDR1 promoters led to a reduction in the level of fluconazole-induced β-galactosidase activity produced by each respective fusion gene.
“Introduction of the mSRE into ERG1, CDR1 or PDR1 promoters led to a reduction in the level of fluconazole-induced β-galactosidase activity produced by each respective fusion gene (Fig 5A).”
Quote in the paperSubstantial claim - Findingown data
Both epitope-tagged UPC2A alleles behaved like the wild-type strain.
“Loss of UPC2A caused hypersensitivity to all these agents (Fig 6A) while both epitope-tagged alleles behaved like the wild-type strain.”
Quote in the paperSubstantial claim - Findingown data
ERG1 was similarly drug induced in both wild-type and upc2AΔ cells.
“ERG1, one of the genes showing the best induction by fluconazole in wild-type cells and most prominent peak of Upc2A ChIP-seq density (See S3 Table), was similarly drug induced in both wild-type and upc2AΔ cells.”
Quote in the paperSubstantial claim - Findingown data
There are 117 genes that are only FLC-inducible in the presence of Upc2A.
“However, there are 117 genes that are only FLC-inducible in the presence of Upc2A.”
Quote in the paperSubstantial claim - Findingown data
The bound regions for Pdr1 and Upc2A extensively overlap in the upstream region of CDR1.
“The bound regions for Pdr1 and Upc2A extensively overlap in the upstream region of CDR1.”
Quote in the paperSubstantial claim - Findingown data
The reduction in fluconazole resistance caused by mSRE-containing CDR1 was modestly enhanced by the simultaneous loss of the SRE from the PDR1 gene.
“This was modestly enhanced by the simultaneous loss of the SRE from the PDR1 gene.”
Quote in the paperSubstantial claim - Findingown data
ERG8 was not seen to contain a detectable ChIP-seq peak for Upc2A binding.
“Strikingly, ERG8 was not seen to contain a detectable ChIP-seq peak for Upc2A binding.”
Quote in the paperSubstantial claim - Findingown data
Only 11 genes were observed to be elevated at least 1.4-fold in the presence of G898D UPC2A.
“There were only 11 genes observed to be elevated at least 1.4-fold.”
Quote in the paperSubstantial claim - Findingown data
Nine of the eleven genes elevated by G898D UPC2A encoded products involved in ergosterol biosynthesis.
“A striking feature shared by these genes was that nine of eleven encoded products that were involved in the biosynthesis of ergosterol.”
Quote in the paperSubstantial claim - Findingown data
Pdr1-regulated genes that were also associated with SREs exhibited less dependence on the presence of Upc2A for fluconazole induction than most ERG genes.
“Pdr1-regulated genes that were also associated with SREs exhibited less dependence on the presence of Upc2A for fluconazole induction than seen for most ERG genes.”
Quote in the paperNot a substantial claim - Findingown data
ERG8 was similarly fluconazole-induced in both wild-type and upc2AΔ cells, irrespective of the presence of Upc2A.
“ERG8, encoding an enzyme that functions early in the ergosterol pathway, was also similarly fluconazole-induced in both gene backgrounds, irrespective of the presence of Upc2A.”
Quote in the paperSubstantial claim - Findingown data
PDR16 and RSB1 were repressed by the presence of fluconazole in wild-type cells.
“Two other Pdr1 target genes (PDR16, RSB1) were repressed by the presence of fluconazole in wild-type cells and their expression lowered further when upc2AΔ cells were treated with fluconazole.”
Quote in the paperNot a substantial claim - Findingown data
CDR1 fluconazole induction was reduced upon loss of Upc2A.
“CDR1 fluconazole induction was reduced upon loss of Upc2A but PDR1 was similarly induced irrespective of the UPC2A background (Fig 3B).”
Quote in the paperSubstantial claim - Findingown data
The presence of the G898D Upc2A protein led to enhanced expression of multiple genes involved in ergosterol biosynthesis.
“As we have seen for ERG11 (Fig 1B and 1C), the presence of the G898D Upc2A protein led to enhanced expression of multiple genes involved in ergosterol biosynthesis.”
Quote in the paperSubstantial claim - Findingown data
The CDR1 SRE exhibited two DNase I hypersensitive sites linked to Upc2A binding.
“The CDR1 SRE exhibited two DNase I hypersensitive sites linked to Upc2A binding while the PDR1 SRE showed a clear protected region but no associated hypersensitive site.”
Quote in the paperNot a substantial claim - Findingown data
GO term analysis of this class indicated that the top enriched categories were involved in translation and the ribosome (60 total).
“GO term analysis of this class of genes indicated that the top enriched categories were involved in translation and the ribosome (60 total).”
Quote in the paperNot a substantial claim - Findingown data
The simplest class of fluconazole-induced genes are represented by the 53 direct target genes.
“The simplest class of fluconazole-induced genes are represented by the 53 direct target genes.”
Quote in the paperNot a substantial claim - Findingown data
The major reduction in fluconazole resistance was caused by the presence of the mSRE-containing form of the CDR1 gene.
“The major reduction in fluconazole resistance was caused by the presence of the mSRE-containing form of the CDR1 gene.”
Quote in the paperSubstantial claim - Findingown data
PDR16 and RSB1 expression was lowered further when upc2AΔ cells were treated with fluconazole.
“Two other Pdr1 target genes (PDR16, RSB1) were repressed by the presence of fluconazole in wild-type cells and their expression lowered further when upc2AΔ cells were treated with fluconazole.”
Quote in the paperNot a substantial claim - Findingown data
Genes encoding enzymes that function later in ergosterol biosynthesis, such as ERG11, were induced by fluconazole at least two-fold in wild-type cells.
“Genes encoding enzymes that function later in ergosterol biosynthesis (like ERG11) were induced by fluconazole at least two-fold in wild-type cells but depressed by at least two-fold in a upc2AΔ background.”
Quote in the paperSubstantial claim - Findingown data
The next highest categories were plasma membrane or amino acid transmembrane transport and represented 74 genes.
“The next highest categories were plasma membrane or amino acid transmembrane transport and represented 74 genes.”
Quote in the paperNot a substantial claim - Findingown data
Expression of ERG10, ERG13, HMG1 and ERG20 was strongly depressed under fluconazole conditions in the absence of UPC2A.
“ERG10, ERG13, HMG1 and ERG20, which all encode early steps in ergosterol biosynthesis, were not influenced by fluconazole challenge in wild-type cells although expression of these genes was strongly depressed under these same conditions in the absence of UPC2A.”
Quote in the paperSubstantial claim - Findingown data
The wild-type ERG1 probe produced two different species of protein:DNA complex.
“The wild-type ERG1 probe produced two different species of protein:DNA complex, possibly corresponding to either one or two binding sites being occupied with Upc2A.”
Quote in the paperSubstantial claim - Findingown data
Genes encoding enzymes that function later in ergosterol biosynthesis were depressed by at least two-fold in a upc2AΔ background.
“Genes encoding enzymes that function later in ergosterol biosynthesis (like ERG11) were induced by fluconazole at least two-fold in wild-type cells but depressed by at least two-fold in a upc2AΔ background.”
Quote in the paperSubstantial claim - Findingown data
Fluconazole induction of Pdr1 was reduced when the SRE was removed from the PDR1 promoter.
“Expression of Pdr1 was not affected when the CDR1 SRE was removed but fluconazole induction of Pdr1 was reduced when the SRE was removed from the PDR1 promoter.”
Quote in the paperSubstantial claim - Findingown data
Loss of UPC2A reduced basal expression of FKS1 by 50%.
“Loss of UPC2A reduced basal expression of FKS1 by 50% and had a modest effect on FKS2 (30% reduction) (Fig 6C).”
Quote in the paperSubstantial claim - Findingnone given
This region shows strong sequence conservation with the 893-898 region of C. glabrata Upc2A.
“This region shows strong sequence conservation with the 893–898 region of C. glabrata Upc2A.”
Quote in the paperNot a substantial claim - Findingown data
Caspofungin induction of FKS2 was unaffected by the absence of Upc2A.
“The addition of caspofungin strongly induced FKS2 expression as expected [35] with this induction unaffected by the absence of Upc2A.”
Quote in the paperSubstantial claim - Findingown data
A binding site for Upc2A lies upstream of PDR1.
“Here we establish that a binding site for Upc2A lies upstream of PDR1 and is required for normal activation of PDR1 expression (Fig 5) as well as many of the other genes controlled directly by Pdr1.”
Quote in the paperSubstantial claim - Findingown data
Loss of the SRE from the FKS1 promoter caused a significant reduction in FKS1-dependent expression of lacZ in the absence of caspofungin.
“Loss of the SRE from the FKS1 promoter caused a significant reduction in FKS1-dependent expression of lacZ in the absence of caspofungin (Fig 6E).”
Quote in the paperSubstantial claim - Findingown data
The G898D UPC2A allele has a surprisingly limited effect on gene expression, triggering significant transcriptional changes almost exclusively in genes associated with ergosterol biosynthesis.
“The G898D UPC2A allele has a surprisingly limited effect on gene expression as this allele was seen to trigger significant transcriptional changes almost exclusively in genes associated with ergosterol biosynthesis (Table 2).”
Quote in the paperNot a substantial claim - Findingcitation
The addition of caspofungin strongly induced FKS2 expression.
“The addition of caspofungin strongly induced FKS2 expression as expected [35] with this induction unaffected by the absence of Upc2A.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] SK Katiyar, 2012, Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance, Antimicrob Agents Chemother source
Not checked in the free run.
- Findingown data
Loss of UPC2A had a modest effect on FKS2, reducing it by 30%.
“Loss of UPC2A reduced basal expression of FKS1 by 50% and had a modest effect on FKS2 (30% reduction) (Fig 6C).”
Quote in the paperNot a substantial claim - Findingown data
A large increase in ChIP-seq peaks is seen for Upc2A when azole-treated cells are compared to untreated cells.
“First, a large increase in ChIP-seq peaks is seen for Upc2A when azole-treated cells are compared to untreated cells.”
Quote in the paperSubstantial claim - Findingown data
The Upc2A binding site upstream of PDR1 is required for normal activation of PDR1 expression.
“Here we establish that a binding site for Upc2A lies upstream of PDR1 and is required for normal activation of PDR1 expression (Fig 5) as well as many of the other genes controlled directly by Pdr1.”
Quote in the paperSubstantial claim - Premisecitation
C. glabrata has high intrinsic resistance to fluconazole.
“First, this pathogen has a high intrinsic resistance to fluconazole [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] MC Arendrup, 2017, Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment, J Infect Dis source
Not checked in the free run.
- Premisecitation
Candida glabrata commonly acquires resistance to azole drugs like fluconazole via mutations in a gene encoding a transcription factor called PDR1.
“Second, high level resistant isolates easily arise that contain gain-of-function (GOF) mutations in a transcription factor-encoding gene called PDR1 [7–9].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [7] JP Vermitsky, 2004, Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor, Antimicrob Agents Chemother source
Not checked in the free run.
- cites [8] HF Tsai, 2006, Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants, Antimicrob Agents Chemother source
Not checked in the free run.
- cites [9] SG Whaley, 2016, Azole Resistance in Candida glabrata, Current infectious disease reports source
Not checked in the free run.
- Premisecitation
Our previous work indicated overlap between Upc2A and Pdr1 target genes.
“Since our previous work indicated overlap between Upc2A and Pdr1 target genes [26]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] BG Vu, 2018, Construction and Use of a Recyclable Marker To Examine the Role of Major Facilitator Superfamily Protein Members in Candida glabrata Drug Resistance Phenotypes, mSphere
Not checked in the free run.
- Premisecitation
Loss of UPC2A is sufficient to strongly reduce fluconazole resistance of a GOF PDR1 mutant allele in C. glabrata.
“First, loss of UPC2A (C. glabrata homologue of C. albicans UPC2) was sufficient to strongly reduce fluconazole resistance of a GOF PDR1 mutant allele [17].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] SG Whaley, 2014, UPC2A is required for high-level azole antifungal resistance in Candida glabrata, Antimicrob Agents Chemother source
Not checked in the free run.
- Interpretationown data
The increased activation of ERG11 in the presence of G898D UPC2A is due to increased function of Upc2A rather than a change in its expression compared to wild-type.
“These data argue that the increased activation seen for ERG11 in the presence of the G898D UPC2A gene was due to increased function of Upc2A rather than a change in its expression compared to the wild-type factor.”
Quote in the paperSubstantial claim - Premisecitation
Genetic means of reducing flux through the ergosterol pathway lead to induction of the Pdr pathway, including PDR1 and CDR1, in a Upc2A-dependent manner.
“Second, genetic means of reducing the flux through the ergosterol pathway led to induction of the Pdr pathway, including PDR1 and CDR1, in a Upc2A-dependent manner [18].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] BG Vu, 2019, Evidence that Ergosterol Biosynthesis Modulates Activity of the Pdr1 Transcription Factor in Candida glabrata., MBio
Not checked in the free run.
- Interpretationown data
The overlap between Upc2A and Pdr1 transcriptional circuits extends well beyond PDR1 and CDR1.
“these new data indicate that the overlap between these two transcriptional circuits extends well beyond the initial two genes.”
Quote in the paperSubstantial claim - Premisenone given
Mutant PDR1 transcription factors exhibit enhanced target gene expression compared to the wild-type allele.
“These mutant transcription factors exhibit enhanced target gene expression when compared to the wild-type allele.”
Quote in the paperNot a substantial claim - Premisecitation
There are no gain-of-function forms currently known for UPC2A.
“there are no gain-of-function (GOF) forms currently known for UPC2A.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [22] H Yang, 2015, Structural mechanism of ergosterol regulation by fungal sterol transcription factor Upc2, Nat Commun source
Not checked in the free run.
- cites [23] CJ Heilmann, 2010, An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans, Antimicrob Agents Chemother source
Not checked in the free run.
- cites [24] SJ Hoot, 2011, An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans, Antimicrob Agents Chemother source
Not checked in the free run.
- Interpretationown data
Upc2A-mediated transcriptional activation extends far beyond its well-appreciated control of ERG gene expression.
“Our data provide a new view of the global importance of Upc2A-mediated transcriptional activation as extending far beyond its well-appreciated control of ERG gene expression.”
Quote in the paperSubstantial claim - Interpretationcitation
G898D UPC2A behaves as a hyperactive transcriptional activator in C. glabrata, as previously seen for G888D Upc2 in S. cerevisiae.
“This is consistent with G898D UPC2A behaving as a hyperactive transcriptional activator in C. glabrata as has previously been seen for G888D Upc2 in S. cerevisiae [25].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] BS Davies, 2005, Dual activators of the sterol biosynthetic pathway of Saccharomyces cerevisiae: similar activation/regulatory domains but different response mechanisms, Mol Cell Biol source
Not checked in the free run.
- Premisecitation
The upc2-1 mutation is a change of glycine to aspartate at position G888D in the carboxy-terminus of ScUpc2.
“The relevant mutation (upc2-1) [19] is a change of a glycine to an aspartate residue located at position (G888D) in the carboxy-terminus of ScUpc2.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] JH Crowley, 1998, A mutation in a purported regulatory gene affects control of sterol uptake in Saccharomyces cerevisiae, J Bacteriol source
Not checked in the free run.
- Interpretationreasoning
Upc2A is a master regulator of lipid and membrane protein biosynthesis.
“These studies provide a new perspective of Upc2A as a master regulator of lipid and membrane protein biosynthesis.”
Quote in the paperSubstantial claim - Interpretationcitation
Fluconazole resistance in C. glabrata likely involves coordination of the Pdr1- and Upc2A-dependent transcriptional circuits.
“Together, these data indicated that fluconazole resistance in C. glabrata was likely to involve coordination of the Pdr1- and Upc2A-dependent transcriptional circuits.”
Quote in the paperSubstantial claim - Interpretationown data
These genes illustrate a more complicated mode of regulation by Upc2A as they can be fluconazole-regulated in the presence or absence of this factor.
“These genes illustrate a more complicated mode of regulation by Upc2A as they can be fluconazole-regulated in the presence or absence of this factor.”
Quote in the paperSubstantial claim - Interpretationown data
The SREs indicated in Fig 4A are likely required for Upc2A binding to each promoter.
“These data argue that the SREs indicated in Fig 4A are likely required for Upc2A binding to each promoter.”
Quote in the paperSubstantial claim - Interpretationown data
The G898D Upc2A protein is a functional hypermorphic form of Upc2A.
“None of these genes were altered in the presence of this gain-of-function form of UPC2A while both ERG1 and AUS1 were elevated (Fig 6B), confirming the functionality of this hypermorphic form of Upc2A.”
Quote in the paperSubstantial claim - Interpretationown data
Each SRE identified in ERG1, CDR1 and PDR1 is required for normal drug-induced promoter activation.
“While some degree of fluconazole inducibility was retained in each mSRE-containing promoter, these data indicate that each SRE identified above is required for normal drug induced promoter activation.”
- Also stated in: § Phenotypes caused by loss of SRE function · plain
“Normal expression of lacZ gene fusions requires the presence of intact SREs in Upc2A target promoters.”
Quote in the paperSubstantial claim - Also stated in: § Phenotypes caused by loss of SRE function · plain
- Interpretationown data
The vast number of fluconazole-induced genes do not depend on the presence of Upc2A.
“These data argue that the vast number of fluconazole-induced genes do not depend on the presence of Upc2A.”
Quote in the paperSubstantial claim - Interpretationreasoning
The coordinate up-regulation of ergosterol biosynthesis genes is likely responsible for the observed increase in fluconazole resistance caused by the G898D UPC2A allele.
“This coordinate up-regulation is likely responsible for the observed increase in fluconazole resistance caused by this allele.”
Quote in the paperSubstantial claim - Interpretationown data
The large number of Upc2A target genes illustrates the breadth of processes transcriptionally influenced by this factor.
“The large number of Upc2A target genes illustrates the breadth of processes that are transcriptionally influenced by this factor.”
Quote in the paperSubstantial claim - Interpretationown data
Upc2A appears to coordinate a broad group of genes including a large number of plasma membrane-localized proteins.
“Upc2A appears to be coordinating a broad group of genes including a large number of plasma membrane-localized proteins (See S1 and S3 Tables).”
Quote in the paperSubstantial claim - Interpretationown data
Comparing the target gene sets defined by Upc2A and Pdr1 suggests a hierarchical relationship between these two transcription factors.
“Comparing the members of the target gene sets defined by Upc2A and Pdr1 suggests a hierarchical relationship between these two transcription factors.”
Quote in the paperSubstantial claim - Interpretationown data
Upc2A transcriptionally regulates FKS1 expression.
“Upc2A transcriptionally regulates FKS1 expression.”
Quote in the paperSubstantial claim - Interpretationown data
Upc2A may provide a link between the genetically separable pathways of azole and echinocandin resistance.
“These two antifungal drugs have been considered to be defined by genetically separable pathways but here we provide evidence that Upc2A may provide a link between them.”
Quote in the paperSubstantial claim - Interpretationcitation
C. glabrata Upc2A accumulates in the nucleus upon ergosterol limitation.
“Based on detailed structural and subcellular localization studies on S. cerevisiae Upc2 [22], we propose that C. glabrata Upc2A accumulates in the nucleus upon ergosterol limitation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] H Yang, 2015, Structural mechanism of ergosterol regulation by fungal sterol transcription factor Upc2, Nat Commun source
Not checked in the free run.
- Rests on an assumption: Fluconazole treatment causes ergosterol limitation in C. glabrata.
- Premisecitation
Little was known about the full range of target genes of Upc2A-like factors.
“Detailed analyses demonstrated the crucial role of these Upc2A-like factors in regulation of ERG gene biosynthesis [30,37,38] but little was known about the full range of their target genes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] PJ Espenshade, 2007, Regulation of sterol synthesis in eukaryotes, Annu Rev Genet source
Not checked in the free run.
- Premisecitation
Loss of UPC2A leads to a profound increase in fluconazole susceptibility, even in the presence of a GOF form of PDR1.
“Loss of UPC2A leads to a profound increase in fluconazole susceptibility, even in the presence of a GOF form of PDR1 [17].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] SG Whaley, 2014, UPC2A is required for high-level azole antifungal resistance in Candida glabrata, Antimicrob Agents Chemother source
Not checked in the free run.
- Interpretationreasoning
Upc2A appears to be a central determinant of the composition of the plasma membrane compartment in C. glabrata.
“Coupled with its control of ergosterol in this membrane, Upc2A appears to be a central determinant of the composition of this membrane compartment in C. glabrata.”
Quote in the paperSubstantial claim - Interpretationown data
This provides an illustration of the overlapping modes of regulation controlling gene expression in response to ergosterol limitation.
“This provides an illustration of the overlapping modes of regulation controlling gene expression in response to ergosterol limitation.”
Quote in the paperNot a substantial claim - Interpretationown data
Our data illuminate the complexity and interrelationship of expression of genes involved in ergosterol biosynthesis with plasma membrane proteins and even the cell wall.
“Finally, our data also illuminate the complexity and interrelationship of expression of genes involved in ergosterol biosynthesis with plasma membrane proteins and even the cell wall.”
Quote in the paperNot a substantial claim - Interpretationown data
The Upc2A binding site upstream of PDR1 is required for many of the other genes controlled directly by Pdr1.
“Here we establish that a binding site for Upc2A lies upstream of PDR1 and is required for normal activation of PDR1 expression (Fig 5) as well as many of the other genes controlled directly by Pdr1.”
Quote in the paperSubstantial claim - Interpretationown data
Construction and analysis of G898D Upc2A demonstrated that there is no particular prohibition on hyperactive alleles of UPC2A existing in this pathogenic yeast.
“Construction and analysis of G898D Upc2A demonstrated that there is no particular prohibition on hyperactive alleles of UPC2A existing in this pathogenic yeast.”
Quote in the paperNot a substantial claim - Interpretationcitation
The interaction between Upc2A and the FKS1 gene provides a connection between azole resistance and echinocandin resistance.
“The finding of the interaction between Upc2A and the FKS1 gene provides an interesting connection between azole resistance, well-known to be impacted by Upc2A [40], and echinocandin resistance.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40] M Nagi, 2011, Transcription factors CgUPC2A and CgUPC2B regulate ergosterol biosynthetic genes in Candida glabrata, Genes Cells source
Not checked in the free run.
- Interpretationown data
The ERG genes are especially sensitive to the level of activity of Upc2A.
“While the full range of Upc2A target genes illustrate the global importance of this transcription factor, the ERG genes are especially sensitive to the level of activity of this regulator.”
Quote in the paperSubstantial claim
- May combine two claims. 42
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 23
May combine two claims.
Findingown dataThe presence of the G898D UPC2A gene leads to strong elevation of ERG11 transcription in the absence of fluconazole but has no significant effect on other tested genes.
“The presence of the G898D UPC2A gene led to a strong elevation of ERG11 transcription in the absence of fluconazole but had no significant effect on the other genes (Fig 1B).”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Findingown dataThe G898D UPC2A allele supports normal fluconazole induction of Cdr1 and shows a modest reduction (~80% of wild-type) in Pdr1 activation.
“The presence of the G899D UPC2A allele supported normal fluconazole induction of Cdr1 and showed a modest reduction (~80% of wild-type) in Pdr1 activation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAll these genes are Upc2A target loci but exhibit unique patterns of association with this factor.
“While all these genes are Upc2A target loci, they exhibited unique patterns of association with this factor.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataChIP-seq data indicated Upc2A bound to roughly 1000 genes and that this binding was highly induced by fluconazole.
“ChIP-seq data indicated Upc2A bound to roughly 1000 genes and that this binding was highly induced by fluconazole.”
- Also stated in: § Global analysis of Upc2A direct transcriptional targets · plain
“The largest number of bound genes was seen for the wild-type factor in the presence of fluconazole (>1000 promoters bound).”
Quote in the paperSubstantial claim- Also stated in: § Global analysis of Upc2A direct transcriptional targets · plain
May combine two claims.
Findingown dataThe central CGTA sequence is conserved between C. glabrata and S. cerevisiae, although the C. glabrata element has a nearby conserved element (CACAGA) with relatively constant spacing.
“The central CGTA sequence is conserved between C. glabrata and S. cerevisiae, although the C. glabrata element has a nearby conserved element (CACAGA) that shows a relatively constant spacing.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFluconazole treatment elevates transcription of all Upc2A target genes, but elevated ERG11 mRNA levels seen in the absence of drug are not further induced by fluconazole when G898D Upc2A is present.
“Treatment with fluconazole elevated transcription of all Upc2A target genes although the elevated ERG11 mRNA levels seen in the absence of drug were not further induced by fluconazole when G898D Upc2A was present.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe majority of fluconazole-induced genes (542) were not dependent on the presence of Upc2A, while 64 genes were fluconazole-induced, required Upc2A but were not bound by this factor.
“The majority of fluconazole-induced genes (542) were not dependent on the presence of Upc2A while 64 genes were fluconazole-induced, required the presence of Upc2A but were not bound by this factor.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLoss of UPC2A caused hypersensitivity to caspofungin, caffeine and high pH.
“Loss of UPC2A caused hypersensitivity to all these agents (Fig 6A) while both epitope-tagged alleles behaved like the wild-type strain.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOnly the group of 201 genes showed any significant GO term enrichment, with response to stress and glycogen catabolism being the top two categories.
“Only the group of 201 genes showed any significant GO term enrichment with specific groups of genes involved in the response to stress and glycogen catabolism being the top two categories.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe PDR1 SRE showed a clear protected region but no associated hypersensitive site.
“The CDR1 SRE exhibited two DNase I hypersensitive sites linked to Upc2A binding while the PDR1 SRE showed a clear protected region but no associated hypersensitive site.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCDR1 and PDR1 probes both formed primarily a single size of complex that was greatly diminished when the mutant SRE probe was used.
“CDR1 and PDR1 probes both formed primarily a single size of complex that was greatly diminished when the mutant SRE probe was used.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLoss of the SRE from the CDR1 promoter caused a significant drop in expression when cells were treated with fluconazole, and this drop was enhanced when combined with the mSRE version of the PDR1 gene.
“Loss of the SRE from the CDR1 promoter caused a significant drop in expression when cells were treated with fluconazole that was enhanced when combined with the mSRE version of the PDR1 gene.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOnly 53 genes required the presence of Upc2A DNA-binding activity to be induced by fluconazole, while 274 were induced either in the presence or absence of UPC2A, although all these genes were bound by Upc2A.
“Strikingly, only 53 genes required the presence of Upc2A DNA-binding activity to be induced by fluconazole while 274 were induced either in the presence or the absence of the UPC2A gene, although all these genes were bound by Upc2A.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCDR1 is a Upc2A target gene that is also regulated by Pdr1.
“CDR1 represents a Upc2A target gene that is also regulated by Pdr1.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSimilar reductions in Cdr1 levels were seen in the absence of fluconazole, with removal of the SRE from both CDR1 and PDR1 causing the largest reduction.
“Similar reductions in Cdr1 levels were seen in the absence of fluconazole, again with removal of the SRE from both CDR1 and PDR1 causing the largest reduction in Cdr1 levels.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe ERG1 promoter exhibited some of the strongest binding detected by ChIP-seq.
“We selected ERG1 for analysis as the promoter for this gene exhibited some of the strongest binding detected by ChIP-seq”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe other two categories of fluconazole-regulated Upc2A-bound genes were either induced in both wild-type and upc2AΔ cells (201 genes) or only in the absence of UPC2A (73 genes).
“The other two categories of fluconazole-regulated Upc2A-bound genes were either induced in both wild-type and upc2AΔ cells (201 genes) or only in the absence of UPC2A (73 genes).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThese 53 genes are both bound by Upc2A and respond to regulation via this factor.
“These genes are both bound by Upc2A and respond to regulation via this factor.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe ERG1 promoter showed the largest protected region of DNA and a strong DNase I hypersensitive site located immediately upstream of the SRE.
“The ERG1 promoter, which contains an everted pair of SREs (Fig 4A), showed the largest protected region of DNA and a strong DNase I hypersensitive site located immediately upstream of the SRE (Fig 4B).”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationPdr1 DNA-binding is strongly upregulated in ρ0 cells, likely due in part to the large increase in PDR1 expression in this background compared to wild-type cells.
“Pdr1 DNA-binding was strongly upregulated in ρ0 cells, likely due in part to the large increase in PDR1 expression in this background compared to wild-type cells [31].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] S Paul, 2014, Identification of Genomic Binding Sites for Candida glabrata Pdr1 Transcription Factor in Wild-Type and rho0 Cells, Antimicrob Agents Chemother source
Not checked in the free run.
May combine two claims.
Findingown dataThe G898D Upc2A mutant protein shows a constitutively high number of ChIP-seq peaks that is not significantly altered by azole challenge.
“Second, the G898D Upc2A mutant protein shows constitutively high number of ChIP-seq peaks that is not significantly altered by azole challenge.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe wild-type FKS1 probe was strongly reduced in mobility when incubated with Upc2A, while the mSRE-containing probe exhibited a band of reduced intensity upon loss of this sequence element.
“The wild-type FKS1 probe was strongly reduced in mobility when incubated with Upc2A while the mSRE-containing probe exhibited a band of reduced intensity upon loss of this sequence element.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOnly ~50 genes were both bound by Upc2A and dependent on Upc2A for fluconazole induction while 880 were induced in the presence of fluconazole independent of Upc2A.
“However, only ~50 genes were both bound by Upc2A and dependent on Upc2A for fluconazole induction while 880 were induced in the presence of fluconazole independent of Upc2A (Fig 3A).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationGOF PDR1 alleles exhibit high levels of target gene expression and drive robust fluconazole resistance primarily through induction of expression of the ATP-binding cassette transporter-encoding gene CDR1.
“The GOF PDR1 alleles exhibit high levels of target gene expression and drive robust fluconazole resistance primarily through induction of expression of the ATP-binding cassette transporter-encoding gene CDR1 [10,11].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10] D Sanglard, 1999, The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents, Antimicrob Agents Chemother source
Not checked in the free run.
- cites [11] S Paul, 2014, Multidrug resistance in fungi: regulation of transporter-encoding gene expression, Frontiers in physiology source
Not checked in the free run.
May combine two claims.
Interpretationown dataUpc2A impacts the Pdr1-Cdr1 system and modulates resistance to caspofungin.
“Finally, we provide evidence that Upc2A impacts the Pdr1-Cdr1 system and also modulates resistance to caspofungin.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationFluconazole and ρ0 cells both involve a signal that activates the wild-type versions of Upc2A and/or Pdr1.
“We selected these two conditions for comparison since both involve a signal that activates the wild-type versions of Upc2A and/or Pdr1 (fluconazole or ρ0 cells, respectively) [8,32].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [8] HF Tsai, 2006, Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants, Antimicrob Agents Chemother source
Not checked in the free run.
- cites [32] S Paul, 2011, Regulation of the CgPdr1 transcription factor from the pathogen Candida glabrata, Eukaryot Cell source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenUpc2A serves as a key coordinator of the biosynthesis of lipids and proteins destined to function in the membrane environment.
“Upc2A appears to serve as a key coordinator of the biosynthesis of lipids and proteins that are destined to function in this membrane environment.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationUpc2A appears to accumulate inside the nucleus upon ergosterol limitation where it binds to SRE-containing promoters.
“These data agree with the model proposed earlier for ScUpc2 that Upc2A appeared to accumulate inside the nucleus upon ergosterol limitation where the factor then binds to SRE-containing promoters [22].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] H Yang, 2015, Structural mechanism of ergosterol regulation by fungal sterol transcription factor Upc2, Nat Commun source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn C. albicans, CaUpc2 is the primary transcriptional activator of CaERG11 and other ergosterol biosynthetic pathway genes.
“CaUpc2, the primary transcriptional activator of CaERG11 and other ergosterol biosynthetic pathway genes [16].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] SA Flowers, 2012, Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans, Eukaryot Cell source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFluconazole resistance is most commonly caused in C. glabrata by substitution mutations within the PDR1 gene.
“Fluconazole resistance is most commonly caused in C. glabrata by substitution mutations within the PDR1 gene (See [6,21] for a review).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [6] MC Arendrup, 2017, Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment, J Infect Dis source
Not checked in the free run.
- cites [21] KR Healey, 2018, Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata, J Fungi (Basel).
Not checked in the free run.
May combine two claims.
PremisecitationUpc2A is an activator of expression of both CDR1 and PDR1.
“Our previous experiments have identified Upc2A as an activator of expression of both the ATP-binding cassette transporter-encoding gene CDR1 and the PDR1 gene encoding a key transcriptional activator of CDR1 [26].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] BG Vu, 2018, Construction and Use of a Recyclable Marker To Examine the Role of Major Facilitator Superfamily Protein Members in Candida glabrata Drug Resistance Phenotypes, mSphere
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationERG8 is in the earlier part of the ergosterol biosynthetic pathway while all other enzymes participate in the conversion of farnesyl pyrophosphate to ergosterol.
“ERG8 is in the earlier part of the ergosterol biosynthetic pathway while all other enzymes participate in the conversion of farnesyl pyrophosphate to ergosterol (recently reviewed in [33]).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] T Jorda, 2020, Regulation of Ergosterol Biosynthesis in Saccharomyces cerevisiae, Genes (Basel) source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe complex responses to fluconazole treatment in C. glabrata are evidence for a multifactorial transcriptional network regulating ERG gene expression in which Upc2A participates as both a direct regulator of later pathway genes and an indirect regulator of early pathway genes.
“We interpret these complex responses to fluconazole treatment in C. glabrata as evidence for a multifactorial transcriptional network regulating ERG gene expression in which Upc2A participates as both a direct (later pathway genes) and indirect (early pathway genes) regulator.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataUpc2A impacts a wide range of cellular processes as well as its well-described control of expression of genes involved in the ergosterol biosynthetic pathway.
“Together, these data strongly suggest that Upc2A impacts a wide range of cellular process as well as its well-described control of expression of genes involved in the ergosterol biosynthetic pathway.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe DNA-binding activity of wild-type but not G898D Upc2A is increased by fluconazole, possibly by an increase in nuclear localization.
“these data support the view that the DNA-binding activity of wild-type but not G898D Upc2A is increased by the presence of fluconazole, possibly by an increase in nuclear localization [22].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] H Yang, 2015, Structural mechanism of ergosterol regulation by fungal sterol transcription factor Upc2, Nat Commun source
Not checked in the free run.
May combine two claims.
PremisecitationCaffeine and high pH are cell wall stresses and reflect general cell wall dysfunction.
“Caffeine and high pH are cell wall stresses and reflect general cell wall dysfunction [34].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34] BB Fuchs, 2009, Our paths might cross: the role of the fungal cell wall integrity pathway in stress response and cross talk with other stress response pathways, Eukaryot Cell source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe SREs present in CDR1 and PDR1 are required for normal expression of these genes and for full fluconazole resistance.
“Together, these data demonstrate that the SREs present in CDR1 and PDR1 are required for normal expression of these genes and for full fluconazole resistance.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenChIP-seq read quality was confirmed using FastQC.
“Read quality was confirmed using FastQC (Babraham Bioinformatics).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataLoss of Upc2A has clear phenotypes but is certainly not the only regulator of ERG gene expression and fluconazole induction in C. glabrata.
“Additionally, loss of Upc2A has clear phenotypes but is certainly not the only regulator of ERG gene expression and fluconazole induction in C. glabrata.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningUpc2A provides overarching control of the Pdr1 regulon and also a variety of other genes not under Pdr1 control, linking these classes through common transcriptional regulation.
“We suggest Upc2A provides overarching control of both the Pdr1 regulon but also a variety of other genes that are not under Pdr1 control, serving to link these different classes of genes through this common transcriptional regulation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenRNA quantity and purity were determined by spectrophotometer and verified using a Bioanalyzer 2100.
“The quantity and purity of RNA were determined by spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE) and verified using a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataUpc2A-mediated gene activation is required for normal expression of FKS1 and wild-type caspofungin resistance.
“These data provide evidence that Upc2A-mediated gene activation is required for normal expression of FKS1 and wild-type caspofungin resistance.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA ChIP-chip experiment found that C. albicans Upc2 associates with the CDR1 gene.
“A ChIP-chip experiment was carried out on C. albicans Upc2 and this factor was found to associate with the CDR1 gene in this species [39].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39] S Znaidi, 2008, Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance, Eukaryot Cell source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe clones used for Upc2A DNA binding domain expression were sequence-verified.
“Correct clones were sequenced verified and transformed into the BL21 DE3 E. coli expression strain (Thermo Fisher, Waltham, MA).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
Interpretationown dataThese data provide important new appreciation for the expansive role of Upc2A in control of gene expression.
“These data provide important new appreciation for the expansive role of Upc2A in control of gene expression.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe majority of C. albicans UPC2 GOF alleles cluster in a region of the protein between residues 642 and 648.
“An interesting feature of the majority of C. albicans UPC2 GOF alleles is these all cluster with a region of the protein between residues 642 and 648 [16].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] SA Flowers, 2012, Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans, Eukaryot Cell source
Not checked in the free run.
May combine two claims.
Interpretationown dataERG gene regulation is an important task for Upc2A but this factor clearly impacts transcription of a broad range of genes affecting multiple aspects of the plasma membrane.
“ERG gene regulation is an important task for Upc2A but this factor clearly impacts transcription of a broad range of genes affecting multiple aspects of the plasma membrane.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenRT-qPCR data reported are from two biological replicates with two technical replicates of each.
“Data reported are from two biological replicates with two technical replicates of each.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThese data are consistent with a model in which Upc2A nuclear accumulation is enhanced upon ergosterol limitation and this regulation requires the function of the region containing G898 in the C-terminus of this factor.
“These data are consistent with a model in which Upc2A nuclear accumulation is enhanced upon ergosterol limitation and this regulation requires the function of the region containing G898 in the C-terminus of this factor.”
Quote in the paperSubstantial claim- Rests on an assumption: Fluconazole treatment causes ergosterol limitation in C. glabrata.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe S. cerevisiae UPC2-1 allele, from which G898D UPC2A was derived, was originally isolated on the basis of permitting aerobic sterol uptake.
“The S. cerevisiae UPC2-1 allele, from which we derived the G898D UPC2A, was originally isolated on the basis of permitting aerobic sterol uptake [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] JH Crowley, 1998, A mutation in a purported regulatory gene affects control of sterol uptake in Saccharomyces cerevisiae, J Bacteriol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe connection between Upc2A and Pdr1 in C. glabrata may be a unique feature of this yeast and could help explain its high level of intrinsic azole resistance.
“This suggests the possibility that this C. glabrata connection between Upc2A and Pdr1 is a unique feature of this yeast and could help explain the high level of intrinsic azole resistance seen in this organism.”
Quote in the paperSubstantial claim- Rests on an assumption: C. glabrata has a high level of intrinsic azole resistance.
- Rests on an assumption: There has been no follow-up linking C. albicans Upc2 with the Tac1 transcription factor or S. cerevisiae Upc2 with either ScPDR1 or ScPDR3.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe conserved location of these hypermorphic alleles suggests the possibility that a common function is being disrupted in both organisms.
“The conserved location of these hypermorphic alleles suggests the possibility that a common function is being disrupted in both organisms.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataChIP-seq experiments were performed in duplicate.
“The reads from duplicate experiments were combined and mapped to the C. glabrata CBS138 genome using HISAT2 [43].”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll constructs were verified by Sanger sequencing.
“All constructs were verified by Sanger sequencing (University of Iowa Genomic Core)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationExtensive previous work on Upc2A homologues in both S. cerevisiae and C. albicans was generally done prior to the availability of modern genomic approaches like ChIP- and RNA-seq.
“Extensive previous work on Upc2A homologues in both S. cerevisiae and C. albicans was generally done prior to the availability of modern genomic approaches like ChIP- and RNA-seq (reviewed in [36]).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] PJ Espenshade, 2007, Regulation of sterol synthesis in eukaryotes, Annu Rev Genet source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationUPC2 mutations in C. albicans have been found in multiple clinical strains and appear to be much more commonly isolated.
“UPC2 mutations in C. albicans have been found in multiple clinical strains and appear to be much more commonly isolated [23,24].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [23] CJ Heilmann, 2010, An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans, Antimicrob Agents Chemother source
Not checked in the free run.
- cites [24] SJ Hoot, 2011, An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans, Antimicrob Agents Chemother source
Not checked in the free run.
May combine two claims.
InterpretationreasoningERG genes are an important set of genetic targets for Upc2A but are a small fraction of the whole.
“Clearly, the ERG genes are an important set of genetic targets but these are a small fraction of the whole.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDetailed analyses demonstrated the crucial role of Upc2A-like factors in regulation of ERG gene biosynthesis.
“Detailed analyses demonstrated the crucial role of these Upc2A-like factors in regulation of ERG gene biosynthesis [30,37,38] but little was known about the full range of their target genes.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [30] A Vik, 2001, Upc2p and Ecm22p, dual regulators of sterol biosynthesis in Saccharomyces cerevisiae, Mol Cell Biol source
Not checked in the free run.
- cites [37] PM Silver, 2004, Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism, Eukaryot Cell source
Not checked in the free run.
- cites [38] S MacPherson, 2005, Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes, Antimicrob Agents Chemother source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenWestern immunoblot target band fluorescence intensity was normalized against tubulin fluorescence intensity and compiled from 2 biological replicate experiments and 2 technical replicates in each experiment, giving 4 replicates in total.
“Detected target band fluorescence intensity was normalized against tubulin fluorescence intensity and compiled from 2 biological replicate experiments and 2 technical replicates in each experiment, giving 4 replicates in total.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenThe limited spectrum of genes induced by G898D Upc2A may reflect more complex requirements at these promoters for their activation beyond Upc2A occupancy.
“The limited spectrum of genes that is induced by G898D Upc2A may reflect more complex requirements at these promoters for their activation beyond Upc2A occupancy.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Genes bound by Upc2A in ChIP-seq and responsive to Upc2A are direct transcriptional targets of Upc2A.
“The simplest class of fluconazole-induced genes are represented by the 53 direct target genes. These genes are both bound by Upc2A and respond to regulation via this factor.”
The paper relies on this without support.
C. glabrata has a high level of intrinsic azole resistance.
“could help explain the high level of intrinsic azole resistance seen in this organism.”
The paper relies on this without support.
There has been no follow-up linking C. albicans Upc2 with the Tac1 transcription factor or S. cerevisiae Upc2 with either ScPDR1 or ScPDR3.
“To the best of our knowledge, there has been no follow-up linking C. albicans Upc2 with the Tac1 transcription factor (key regulator of CDR1 transcription) or S. cerevisiae Upc2 with either ScPDR1 or ScPDR3.”
The paper relies on this without support.
No other S. cerevisiae UPC2 hypermorphic alleles are known.
“Strikingly, no other S. cerevisiae UPC2 hypermorphic alleles are known.”
The paper relies on this without support.
Ergosterol production and its synchronization with biogenesis of membrane proteins in the plasma membrane is central to a fungal cell producing a normally functioning membrane that can allow growth.
“The importance of ergosterol production and its synchronization with biogenesis of membrane proteins in the plasma membrane is central to a fungal cell producing a normally functioning membrane that can allow growth.”
The paper relies on this without support.
Fluconazole treatment causes ergosterol limitation in C. glabrata.
“we propose that C. glabrata Upc2A accumulates in the nucleus upon ergosterol limitation.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
C. glabrata Upc2A controls expression of genes beyond those involved in ergosterol biosynthesis, including genes associated with translation and plasma membrane constituents.
“Intriguingly, recent work demonstrated an expansive role of C. glabrata Upc2A (C. glabrata homologue of C. albicans Upc2) in controlling the expression of genes beyond those involved in ergosterol biosynthesis, including those associated with translation and plasma membrane constituents27.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [27]
Upc2A also regulates CDR1 expression and extensive overlap exists between the regulatory networks mediated by Upc2A and Pdr1 in C. glabrata.
“Recently, it was demonstrated that the zinc cluster transcription factor Upc2A also regulates CDR1 expression and that extensive overlap exists between the regulatory networks mediated by Upc2A and Pdr1 in C. glabrata27,59.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
ERG8 is described as both Upc2A-dependent and Upc2A-independent
MajorERG8 is listed among genes that require Upc2A for fluconazole induction, but a later passage says it is similarly induced with and without Upc2A.
“These Upc2A-dependent but indirect targets include ERG4, ERG8, ERG9, ERG24, ERG26 and ERG27.”
“ERG8, encoding an enzyme that functions early in the ergosterol pathway, was also similarly fluconazole-induced in both gene backgrounds, irrespective of the presence of Upc2A.”
Gain-of-function allele is called G899D once
MinorThe allele characterized throughout the paper is G898D UPC2A, but this passage calls it G899D UPC2A.
“The presence of the G899D UPC2A allele supported normal fluconazole induction of Cdr1”
“This residue was replaced with an aspartate to form the G898D UPC2A form of the gene.”
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · see citing works
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386 · see citing works
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
Kim, D., Paggi, J. M., Park, C., Bennett, C., & Salzberg, S. L. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0201-4 · Cited by 15,022 · see citing works
Transformation of intact yeast cells treated with alkali cations
Ito, H., Fukuda, Y., Murata, K., & Kimura, A. (1983) · Journal of Bacteriology · doi:10.1128/jb.153.1.163-168.1983 · Cited by 7,518 · see citing works
Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown
Pertea, M., Kim, D., Pertea, G. M., Leek, J. T., & Salzberg, S. L. (2016) · Nature Protocols · doi:10.1038/nprot.2016.095 · Cited by 6,708 · see citing works
A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae
Schmitt, M. E., Brown, T. A., & Trumpower, B. L. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.10.3091 · Cited by 1,344 · see citing works
ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data
Zhu, L., Gazin, C., Lawson, N., Pagès, H., Lin, S. M., Lapointe, D. S., & Green, M. R. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-237 · Cited by 1,144 · see citing works
Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825 · see citing works
Love, M. I., Huber, W. K., & Anders, S. (2014) · Cited by 718 · see citing works
Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment
Arendrup, M. C., & Patterson, T. F. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix131 · Cited by 707 · see citing works
Regulation of Sterol Synthesis in Eukaryotes
Espenshade, P. J., & Hughes, A. L. (2007) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130315 · Cited by 593 · see citing works
Regulation of Ergosterol Biosynthesis in Saccharomyces cerevisiae
Jordá, T., & Puig, S. (2020) · Genes · doi:10.3390/genes11070795 · Cited by 489 · see citing works
How to bolster the antifungal pipeline
Denning, D. W., & Bromley, M. (2015) · Science · doi:10.1126/science.aaa6097 · Cited by 481 · see citing works
Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470 · see citing works
Coste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407 · see citing works
Morschhäuser, J., Barker, K. S., Liu, T. T., Blaß-Warmuth, J., Homayouni, R., & Rogers, P. D. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030164 · Cited by 355 · see citing works
Self-citationSanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A., & Bille, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2753 · Cited by 337 · see citing works
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Arastehfar, A. A., Gabaldón, T., Garcia‐Rubio, R., Jenks, J. D., Hoenigl, M., Salzer, H. J. F., İlkit, M., Lass‐Flörl, C., & Perlin, D. S. (2020) · Antibiotics · doi:10.3390/antibiotics9120877 · Cited by 294 · see citing works
Vermitsky, J.-P., & Edlind, T. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3773-3781.2004 · Cited by 285 · see citing works
Upc2p and Ecm22p, Dual Regulators of Sterol Biosynthesis in <i>Saccharomyces cerevisiae</i>
Vik, Å., & Rine, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6395-6405.2001 · Cited by 277 · see citing works
Triazole Antifungal Agents in Invasive Fungal Infections
Lass‐Flörl, C. (2011) · Drugs · doi:10.2165/11596540-000000000-00000 · Cited by 272 · see citing works
Fuchs, B. B., & Mylonakis, E. (2009) · Eukaryotic Cell · doi:10.1128/ec.00193-09 · Cited by 266 · see citing works
Flowers, S. A., Barker, K. S., Berkow, E. L., Toner, G., Chadwick, S. G., Gygax, S. E., Morschhäuser, J., & Rogers, P. D. (2012) · Eukaryotic Cell · doi:10.1128/ec.00215-12 · Cited by 239 · see citing works
Self-citationMacPherson, S., Akache, B., Weber, S., De Deken, X., Raymond, M., & Turcotte, B. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1745-1752.2005 · Cited by 238 · see citing works
Tsai, H.-F., Krol, A. A., Sarti, K. E., & Bennett, J. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1384-1392.2006 · Cited by 237 · see citing works
Structural mechanism of ergosterol regulation by fungal sterol transcription factor Upc2
Yang, H., Tong, J., Lee, C. W., Ha, S., Eom, S. H., & Im, Y. J. (2015) · Nature Communications · doi:10.1038/ncomms7129 · Cited by 223 · see citing works
Role of <i>Candida albicans</i> Transcription Factor Upc2p in Drug Resistance and Sterol Metabolism
Silver, P. M., Oliver, B. G., & White, T. C. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1391-1397.2004 · Cited by 216 · see citing works
Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
Healey, K. R., & Perlin, D. S. (2018) · Journal of Fungi · doi:10.3390/jof4030105 · Cited by 194 · see citing works
Katiyar, S. K., Alastruey-Izquierdo, A., Healey, K. R., Johnson, M. E., Perlin, D. S., & Edlind, T. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00813-12 · Cited by 148 · see citing works
Heilmann, C. J., Schneider, S., Barker, K. S., Rogers, P. D., & Morschhäuser, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01102-09 · Cited by 142 · see citing works
Self-citationDavies, B. S. J., Wang, H. S., & Rine, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7375-7385.2005 · Cited by 138 · see citing works
Multidrug resistance in fungi: regulation of transporter-encoding gene expression
Paul, S., & Moye-Rowley, W. S. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00143 · Cited by 137 · see citing works
Crowley, J. H., Leak, F. W., Shianna, K. V., Tove, S., & Parks, L. W. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.16.4177-4183.1998 · Cited by 123 · see citing works
McCormack, P. L., & Perry, C. M. (2005) · Drugs · doi:10.2165/00003495-200565140-00009 · Cited by 122 · see citing works
Znaidi, S., Weber, S., Zin Al-Abdin, O., Bomme, P., Saidane, S., Drouin, S., Lemieux, S., De Deken, X., Robert, F., & Raymond, M. (2008) · Eukaryotic Cell · doi:10.1128/ec.00070-08 · Cited by 119 · see citing works
Hoot, S. J., Smith, A. R., Brown, R. P., & White, T. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00995-10 · Cited by 107 · see citing works
AtrR Is an Essential Determinant of Azole Resistance in Aspergillus fumigatus
Paul, S., Stamnes, M., Thomas, G. H., Liu, H., Hagiwara, D., Gomi, K., Filler, S. G., & Moye-Rowley, W. S. (2019) · mBio · doi:10.1128/mbio.02563-18 · Cited by 91 · see citing works
Self-citationCohen, B. D. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.3.799 · Cited by 88 · see citing works
Azole Resistance in Candida glabrata
Whaley, S. G., & Rogers, P. D. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0554-5 · Cited by 85 · see citing works
Self-citationRegulation of the CgPdr1 Transcription Factor from the Pathogen Candida glabrata
Paul, S., Schmidt, J. A., & Moye-Rowley, W. S. (2011) · Eukaryotic Cell · doi:10.1128/ec.00277-10 · Cited by 78 · see citing works
Nagi, M., Nakayama, H., Tanabe, K., Bard, M., Aoyama, T., Okano, M., Higashi, S., Ueno, K., Chibana, H., Niimi, M., et al. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01470.x · Cited by 68 · see citing works
Vu, B. G., Thomas, G. H., & Moye-Rowley, W. S. (2019) · mBio · doi:10.1128/mbio.00934-19 · Cited by 59 · see citing works
Self-citationSiopi, M., Tarpatzi, A., Kalogeropoulou, E., Damianidou, S., Vasilakopoulou, A., Vourli, S., Pournaras, S., & Meletiadis, J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01516-19 · Cited by 59 · see citing works
<i>UPC2A</i> Is Required for High-Level Azole Antifungal Resistance in Candida glabrata
Whaley, S. G., Caudle, K. E., Vermitsky, J.-P., Chadwick, S. G., Toner, G., Barker, K. S., Gygax, S. E., & Rogers, P. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02217-13 · Cited by 52 · see citing works
Self-citationPaul, S., Bair, T. B., & Moye-Rowley, W. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03921-14 · Cited by 45 · see citing works
Emerging Issues in Antifungal Resistance
Perfect, J. R., & Ghannoum, M. A. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.05.003 · Cited by 44 · see citing works
Gallo-Ebert, C., Donigan, M., Stroke, I. L., Swanson, R. N., Manners, M. T., Francisco, J., Toner, G., Gallagher, D., Huang, C.-Y., Gygax, S. E., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01677-13 · Cited by 32 · see citing works
Khakhina, S., Šimoničová, L., & Moye-Rowley, S. (2018) · Molecular Microbiology · doi:10.1111/mmi.13913 · Cited by 27 · see citing works
Jjj1 Is a Negative Regulator of Pdr1-Mediated Fluconazole Resistance in Candida glabrata
Whaley, S., Caudle, K. E., Šimoničová, L., Zhang, Q., Moye-Rowley, S., & Rogers, P. D. (2018) · mSphere · doi:10.1128/msphere.00466-17 · Cited by 21 · see citing works
Self-citationVu, B. G., & Moye-Rowley, S. (2018) · mSphere · doi:10.1128/msphere.00099-18 · Cited by 17 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Molecular mechanisms governing antifungal drug resistance
Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304 · see citing works
Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species
Czajka, K. M., Venkataraman, K., Brabant-Kirwan, D., Santi, S. A., Verschoor, C. P., Appanna, V. D., Singh, R. I., Saunders, D., & Tharmalingam, S. (2023) · Cells · doi:10.3390/cells12222655 · Cited by 196 · see citing works
Candida albicans and Candida glabrata : global priority pathogens
Katsipoulaki, M., Stappers, M. H. T., Malavia, D., Brunke, S., Hube, B., & Gow, N. A. R. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00021-23 · Cited by 174 · see citing works
Burrack, L. S., Todd, R. T., Soisangwan, N., Wiederhold, N. P., & Selmecki, A. (2022) · mBio · doi:10.1128/mbio.00842-22 · Cited by 82 · see citing works
Ergosterol Biosynthesis and Regulation Impact the Antifungal Resistance and Virulence of Candida spp
Eliaš, D., Tóth Hervay, N., & Gbelská, Y. (2024) · Stresses · doi:10.3390/stresses4040041 · Cited by 63 · see citing works
Regulation of Ergosterol Biosynthesis in Pathogenic Fungi: Opportunities for Therapeutic Development
Song, L., Wang, S., Zou, H., Yi, X., Jia, S., Li, R., & Song, J. (2025) · Microorganisms · doi:10.3390/microorganisms13040862 · Cited by 49 · see citing works
The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives
de Souza, C. M., Bezerra, B. T., Mellon, D. A., & de Oliveira, H. C. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100341 · Cited by 35 · see citing works
Upc2-mediated mechanisms of azole resistance in <i>Candida auris</i>
Li, J., Aubry, L., Brandalise, D., Coste, A. T., Sanglard, D., & Lamoth, F. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.03526-23 · Cited by 33 · see citing works
Vu, B. G., & Moye-Rowley, S. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02098-21 · Cited by 28 · see citing works
Self-citationGale, A. N., Pavesic, M. W., Nickels, T. J., Xu, Z., Cormack, B. P., & Cunningham, K. W. (2023) · mSphere · doi:10.1128/msphere.00254-23 · Cited by 27 · see citing works
Eliaš, D., Hervay, N. T., Jacko, J., Morvová, M., Valachovič, M., & Gbelská, Y. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac045 · Cited by 21 · see citing works
Bhakt, P., Raney, M., & Kaur, R. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102485 · Cited by 15 · see citing works
Salazar, S. B., Pinheiro, M. J. F., Sotti-Novais, D., Soares, A. R., Lopes, M. M., Ferreira, T., Rodrigues, V., Fernandes, F., & Mira, N. P. (2022) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkac110 · Cited by 15 · see citing works
Pais, P., Galocha, M., Takahashi‐Nakaguchi, A., Chibana, H., & Teixeira, M. C. (2022) · Microbial Cell · doi:10.15698/mic2022.11.786 · Cited by 15 · see citing works
Ollinger, T. L., Vu, B. G., Murante, D., Parker, J. E., Šimoničová, L., Doorley, L. A., Stamnes, M. A., Kelly, S. L., Rogers, P. D., Moye-Rowley, S., et al. (2021) · mSphere · doi:10.1128/msphere.00830-21 · Cited by 14 · see citing works
Self-citationWang, Y., Xu, J., Abid, F. B., Salah, H., Sundararaju, S., Ismail, K. A., Wang, K., Matthew, L. S., Taj‐Aldeen, S. J., Ibrahim, E. B., et al. (2024) · Microbial Genomics · doi:10.1099/mgen.0.001179 · Cited by 13 · see citing works
Naskar, S., Prajapati, A., & Kaur, R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf025 · Cited by 11 · see citing works
Nonidentical function of Upc2A binding sites in the Candida glabrata CDR1 promoter
Vu, B. G., & Moye-Rowley, S. (2022) · Genetics · doi:10.1093/genetics/iyac135 · Cited by 10 · see citing works
Self-citationZhao, Y., Sun, H., Li, J., Ju, C., & Huang, J. (2022) · Biology · doi:10.3390/biology11020326 · Cited by 10 · see citing works
Соколов, С. С., Volynsky, P. E., Zangieva, O. T., Severin, F. F., Glagoleva, E. S., & Кнорре, Д. А. (2022) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2022.183993 · Cited by 10 · see citing works
Calcineurin is required for Candida glabrata Pdr1 transcriptional activation
Vu, B. G., Šimoničová, L., & Moye-Rowley, S. (2023) · mBio · doi:10.1128/mbio.02416-23 · Cited by 10 · see citing works
Self-citationMeng, Q., Wang, H., Xiao, W., Mai, W., Liu, Y., Xiao, Y., Wang, P., Sui, J., He, X., Yin, F., et al. (2025) · Mycology · doi:10.1080/21501203.2025.2461725 · Cited by 8 · see citing works
Puccetti, G., Badet, T., Flückiger, D., Edel, D., Feurtey, A., Delude, C., Gluck‐Thaler, E., Torriani, S. F. F., Scalliet, G., & Croll, D. (2025) · mBio · doi:10.1128/mbio.02766-25 · Cited by 8 · see citing works
Human Sterols Are Overproduced, Stored and Excreted in Yeasts
Radkohl, A., Schusterbauer, V., Bernauer, L., Rechberger, G. N., Wolinski, H., Schittmayer, M., Birner‐Gruenberger, R., Thallinger, G., Leitner, E., Baeck, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020781 · Cited by 7 · see citing works
Olivares-Yáñez, C., Arias-Inostroza, N., Polanco, R., & Canessa, P. (2025) · iScience · doi:10.1016/j.isci.2025.111783 · Cited by 6 · see citing works
Diagnostics for human pathogenic fungal infections: Current status and future prospects
Huang, X., Moses, M., Nie, L., Wandera, E. A., & Chen, C. (2026) · hLife · doi:10.1016/j.hlife.2025.11.005 · Cited by 5 · see citing works
Birštonas, L., Hortschansky, P., Bauer, I., Alcanzo, E. M., Kühbacher, A., Mertens, B., Müller, C., Brakhage, A. A., & Gsaller, F. (2025) · mBio · doi:10.1128/mbio.01854-25 · Cited by 5 · see citing works
Zhang, J., Jiang, X., Shi, G., Zhang, H., Hu, K., Wu, D., Shao, J., Liu, T., Wang, T., & Wang, C. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.105825 · Cited by 5 · see citing works
Saha, D., Gregor, J. B., Hoda, S., Eastman, K. E., Gutierrez-Schultz, V. A., Navarrete, M., Wisecaver, J. H., & Briggs, S. D. (2024) · mSphere · doi:10.1128/msphere.00524-24 · Cited by 4 · see citing works
Day, A. W., & Kumamoto, C. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298724 · Cited by 3 · see citing works
Eliaš, D., Hervay, N. T., Černáková, L., & Gbelská, Y. (2024) · Journal of Fungi · doi:10.3390/jof10100669 · Cited by 3 · see citing works
Conway, T. P., Vu, B. G., Beattie, S. R., Krysan, D. J., & Moye-Rowley, S. (2024) · mSphere · doi:10.1128/msphere.00792-24 · Cited by 2 · see citing works
Self-citationCandida glabrata YPK2 is a multidrug susceptibility locus
Šimoničová, L., Conway, T. P., Krüger, T., Brakhage, A. A., & Moye-Rowley, S. (2026) · Genetics · doi:10.1093/genetics/iyag176 · Cited by 1 · see citing works
Conway, T. P., Šimoničová, L., & Moye-Rowley, S. (2024) · Genetics · doi:10.1093/genetics/iyae115 · Cited by 1 · see citing works
Cob-Delgado, M., Ruiz-Mayorga, A., Ramírez-Cardoce, M., Cordero-Laurent, E., & Gutierrez, R. (2026) · Medical Mycology · doi:10.1093/mmy/myag004
Pinheiro, M. J. F., Parker, J. E., Ferreira, M. T., Fernandes, F., & Mira, N. P. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03344-25
Aldejohann, A. M., Thielemann, N., Martinez, A. Z., Müller, C., Gräfenhan, T., Kriz, R., Lagler, H., Behr, I. S., Reus, N., Schöninger, A., et al. (2026) · mBio · doi:10.1128/mbio.02731-25
Garg, T., Saini, M., Kumar, A., & MITTAL, D. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.53s.12
Uddin, Z., Tahsin, S., Valíčková, K., Long, T., Macedo, L. F. D., Popencuk, G., Zhao, Y., & Healey, K. R. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03874-25
Yin, J., Yang, S., Xiong, K., Gong, S., & Su, C. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.01865-26
- Authors
- Vu, B. G., Stamnes, M. A., Li, Y., Rogers, P. D., & Moye-Rowley, W. S.
- Affiliations
- University of Iowa (US)
- University of Tennessee Health Science Center (US)
- Venue
- PLOS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-09-30
- Volume
- 17
- Issue
- 9
- Pages
- e1009582
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC8509923
- OpenAlex
- W3202652055
- Semantic Scholar
- e0a00595385d38df357fe32205ff452492e3ccac
- Cited by
- 39
- References
- 50
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 12 · 2023: 4 · 2022: 7 · 2021: 1
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Update notices
- new_version (2021-10-12)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI152494, R01AI131620)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Fungal Plant Pathogen Control
- Keywords
- Candida glabrata, antifungal resistance, azole resistance, fluconazole, PDR1, CDR1, ergosterol biosynthesis, transcriptional regulatory networks, membrane protein biosynthesis, lipogenesis, caspofungin resistance, transcription factor binding sites
- MeSH terms
- Gain of Function Mutation, Antifungal Agents, Genes, Fungal, Mutation, Transcription Factors, Transcription, Genetic, Fluconazole, Gene Expression Regulation, Fungal, Drug Resistance, Fungal, Candida glabrata, Chromatin Immunoprecipitation, Gene Regulatory Networks, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review